Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 3
2018 3
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
Jean SS, Hsieh TC, Lee WS, Hsueh PR, Hsu CW, Lam C. Jean SS, et al. Among authors: hsu cw. Medicine (Baltimore). 2018 Sep;97(39):e12278. doi: 10.1097/MD.0000000000012278. Medicine (Baltimore). 2018. PMID: 30278498 Free PMC article.
Corrigendum to "Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests" [J Microbiol Immunol Infect (2015) 924-933].
Jean SS, Hsieh TC, Hsu CW, Lee WS, Bai KJ, Lam C. Jean SS, et al. Among authors: hsu cw. J Microbiol Immunol Infect. 2018 Feb;51(1):157. doi: 10.1016/j.jmii.2017.01.002. Epub 2017 Feb 6. J Microbiol Immunol Infect. 2018. PMID: 28185779 Free article. No abstract available.
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS, Hsieh TC, Hsu CW, Lee WS, Bai KJ, Lam C. Jean SS, et al. Among authors: hsu cw. J Microbiol Immunol Infect. 2016 Dec;49(6):924-933. doi: 10.1016/j.jmii.2015.06.009. Epub 2015 Aug 14. J Microbiol Immunol Infect. 2016. PMID: 26341302 Free article.
Corrigendum to "Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)" [J Microbiol Immunol Infect 49 (2016) 969-976].
Jean SS, Lee WS, Yu KW, Liao CH, Hsu CW, Chang FY, Ko WC, Chen RJ, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Lam C, Liu CY, Hsueh PR. Jean SS, et al. Among authors: hsu cw. J Microbiol Immunol Infect. 2018 Jun;51(3):423-424. doi: 10.1016/j.jmii.2017.01.001. Epub 2017 Mar 17. J Microbiol Immunol Infect. 2018. PMID: 28325540 Free article. No abstract available.